Neuroscience

Explore the fascinating science of the brain

The key to a healthy aging brain

The key to a healthy aging brain

Targeting the aging brain’s immune system might restore its cognitive function

April 5, 2023

New protein function could explain cause of neurological disease

New protein function could explain cause of neurological disease

Linking actin bundling to Charcot-Marie-Tooth Disease

March 9, 2023

New study shows how protein aggregation can help fight cancer

New study shows how protein aggregation can help fight cancer

Targeting KRAS with Pept-ins™: a new therapeutic strategy for difficult-to-drug proteins

February 28, 2023

New model identifies key player in ALS

New model identifies key player in ALS

Astrocytes discovered to be critical in the abnormal immune response of ALS

February 21, 2023

One million euros for research into motor neuron disease ALS

One million euros for research into motor neuron disease ALS

Ludo Van Den Bosch wins the Generet Award for Rare Diseases

February 16, 2023

The secret of slow human brain growth

The secret of slow human brain growth

Researchers discover a “cellular hourglass” that sets the tempo of brain development.

January 26, 2023

How did human brains get so large?

How did human brains get so large?

Newly found gene sheds light on human brain evolution

November 4, 2022

Possible therapeutic targets identified for ALS and frontotemporal dementia

Possible therapeutic targets identified for ALS and frontotemporal dementia

Leuven research team found key proteins involved in the disease development of ALS and frontotemporal dementia that can become druggable targets

September 13, 2022

Zooming in on bladder issues 2.0

Zooming in on bladder issues 2.0

A new-and-improved technique to analyze bladder function in rodents shifts the paradigm

September 12, 2022

About VIB

VIB’s core mission is to generate disruptive insights in the molecular underpinning of life and to translate these actively into impactful innovations for patients and society. VIB is an independent research institute where some 1,800 top scientists from Belgium and abroad conduct pioneering basic research. As such, they are pushing the boundaries of what we know about molecular mechanisms and how they rule living organisms such as human beings, animals, plants, and microorganisms. Based on a close partnership with five Flemish universities – Ghent University, KU Leuven, University of Antwerp, Vrije Universiteit Brussel, and Hasselt University – and supported by a solid funding program, VIB unites the expertise of all its collaborators and research groups in a single institute. VIB’s technology transfer activities translate research results into concrete benefits for society such as new diagnostics and therapies and agricultural innovations. These applications are often developed by young start-ups from VIB or through collaborations with other companies. This also leads to additional employment and bridges the gap between scientific research and entrepreneurship. VIB also engages actively in the public debate on biotechnology by developing and disseminating a wide range of science-based information. 

More info can be found on www.vib.be.

Contact